NeuroMetrix names new senior vice president of global sales
Prior to joining NeuroMetrix, Mr Christensen was the senior vice president of global sales at Stereotaxis. Prior to Stereotaxis, Mr Christensen was vice president for mid America zone
Voro Therapeutics and Alloy Therapeutics have formed a strategic research partnership to develop tumour-selective, next-generation masked T-cell engager (TCE) therapeutics.
Fovea Pharmaceuticals, a French biopharmaceutical company, has reported positive results from its clinical proof-of-concept trial to assess the therapeutic effect of Prednisporin in patients with persistent allergic conjunctivitis.